- Home
- ALEC vs RBKB Comparison
ALEC vs RBKB Comparison
Compare ALEC & RBKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ALEC | RBKB |
|---|---|---|
| Founded | 2013 | 1860 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 194.3M | 185.5M |
| IPO Year | 2019 | 2018 |
Fundamental Metrics
Financial Performance| Metric | ALEC | RBKB |
|---|---|---|
| Price | $1.86 | $17.39 |
| Analyst Decision | Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $4.83 | N/A |
| AVG Volume (30 Days) | ★ 875.1K | 35.1K |
| Earning Date | 05-04-2026 | 04-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 215.00 |
| EPS | N/A | ★ 0.20 |
| Revenue | ★ $21,045,000.00 | $2,984,000.00 |
| Revenue This Year | $2.03 | N/A |
| Revenue Next Year | $29.87 | N/A |
| P/E Ratio | ★ N/A | $86.15 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.09 | $9.41 |
| 52 Week High | $3.40 | $17.99 |
Technical Indicators
Market Signals| Indicator | ALEC | RBKB |
|---|---|---|
| Relative Strength Index (RSI) | 52.52 | 65.65 |
| Support Level | $1.14 | $15.18 |
| Resistance Level | $2.64 | $17.92 |
| Average True Range (ATR) | 0.15 | 0.42 |
| MACD | 0.05 | 0.05 |
| Stochastic Oscillator | 78.69 | 70.97 |
Price Performance
Historical ComparisonAbout ALEC Alector Inc.
Alector Inc is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases. The company advances a pipeline of product candidates including Nivisnebart (AL101/GSK4527226) for Alzheimer's disease, AL137 for Alzheimer's disease, AL050 for Parkinson's disease and Lewy body dementia, and AL064, an siRNA program targeting tau for Alzheimer's disease and other tauopathies, supported by its proprietary Alector Brain Carrier (ABC) platform designed to improve delivery of therapeutics across the blood-brain barrier.
About RBKB Rhinebeck Bancorp Inc.
Rhinebeck Bancorp Inc is the holding company for Rhinebeck Bank, which is a New York-chartered stock savings bank. It provides a full range of banking and financial services to consumer and commercial customers. Financial services, including investment advisory and financial product sales, are offered through a division of the Bank doing business as Rhinebeck Asset Management. The Bank's primary business activity is accepting deposits from the general public and using those funds together with borrowings, to originate commercial real estate loans (which include multi-family real estate loans and commercial construction loans), commercial business loans and indirect automobile loans, and to purchase one- to four-family residential real estate loans and investment securities.